What is Pancreatic Cancer?

NewsGuard 100/100 Score

Pancreatic cancer is the ninth most common cancer in the United Kingdom, the fourth most common cause of cancer death in the United states and the 12th most common cause of death from cancer worldwide. The condition is more common among those over 60 years of age and rare among those aged under 40.

There are two main types of pancreatic cancer, those that originate in cells that produce enzymes (exocrine cells) and those that originate in cells that produce hormones (endocrine cells).

Around 95% of the pancreatic cancers are exocrine tumors, which can occur anywhere along the length of the organ. The remaining 5% are endocrine tumors and are considered rare.


The pancreas is a large, leaf-shaped gland about six inches in length that lies behind the stomach at the point where the ribs meet the lower end of the breast bone or the sternum. The exocrine pancreas produces digestive enzymes and the endocrine pancreas secretes hormones such as insulin and glucagon. The digestive enzymes help to break food down into smaller fragments for absorption, while insulin and glucagon help regulate the body’s levels of glucose and its uptake as a source of energy.


The symptoms of pancreatic cancer can be mild and vague during the initial stages but as the cancer progresses, the following signs may develop:

  • Abdominal pain
  • Weight loss
  • Fatigue and tiredness
  • Malnutrition
  • Jaundice or yellowish discoloration of the whites of the eyes (sclera), skin and nail beds.

Diagnosis and treatment

As pancreatic cancer rarely causes symptoms in the initial stages, the cancer is usually detected once it has reached the more advanced stages and is less likely to be responsive to treatment.

Treatment depends on where the cancer is located and the stage it has reached. Removal of the tumor and any other cancerous cells is the main goal of treatment. If this is not achievable, treatment will aim to prevent growth of the tumor and any further damage it may cause.

Further Reading

Last Updated: Jun 21, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, June 21). What is Pancreatic Cancer?. News-Medical. Retrieved on May 29, 2024 from https://www.news-medical.net/health/What-is-Pancreatic-Cancer.aspx.

  • MLA

    Mandal, Ananya. "What is Pancreatic Cancer?". News-Medical. 29 May 2024. <https://www.news-medical.net/health/What-is-Pancreatic-Cancer.aspx>.

  • Chicago

    Mandal, Ananya. "What is Pancreatic Cancer?". News-Medical. https://www.news-medical.net/health/What-is-Pancreatic-Cancer.aspx. (accessed May 29, 2024).

  • Harvard

    Mandal, Ananya. 2023. What is Pancreatic Cancer?. News-Medical, viewed 29 May 2024, https://www.news-medical.net/health/What-is-Pancreatic-Cancer.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study unveils link between oral bacteria and pancreatic cancer development in mice